Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA GLENMARK PHARMA ALEMBIC PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 32.2 -31.4 - View Chart
P/BV x 4.4 2.9 154.6% View Chart
Dividend Yield % 0.8 0.3 311.9%  

Financials

 ALEMBIC PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
ALEMBIC PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs792487 162.6%   
Low Rs463349 132.8%   
Sales per share (Unadj.) Rs287.6460.4 62.5%  
Earnings per share (Unadj.) Rs17.413.4 130.1%  
Cash flow per share (Unadj.) Rs31.435.0 89.6%  
Dividends per share (Unadj.) Rs8.002.50 320.0%  
Avg Dividend yield %1.30.6 213.1%  
Book value per share (Unadj.) Rs222.3335.1 66.3%  
Shares outstanding (eoy) m196.56282.17 69.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.9 240.4%   
Avg P/E ratio x36.131.3 115.5%  
P/CF ratio (eoy) x20.011.9 167.5%  
Price / Book Value ratio x2.81.2 226.4%  
Dividend payout %46.018.7 246.0%   
Avg Mkt Cap Rs m123,402117,953 104.6%   
No. of employees `000NANA-   
Total wages/salary Rs m11,69127,810 42.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,526129,901 43.5%  
Other income Rs m303,168 1.0%   
Total revenues Rs m56,557133,069 42.5%   
Gross profit Rs m6,77215,125 44.8%  
Depreciation Rs m2,7546,113 45.1%   
Interest Rs m5023,496 14.4%   
Profit before tax Rs m3,5468,685 40.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1264,911 2.6%   
Profit after tax Rs m3,4203,774 90.6%  
Gross profit margin %12.011.6 102.9%  
Effective tax rate %3.656.5 6.3%   
Net profit margin %6.12.9 208.2%  
BALANCE SHEET DATA
Current assets Rs m29,13998,737 29.5%   
Current liabilities Rs m16,40850,455 32.5%   
Net working cap to sales %22.537.2 60.6%  
Current ratio x1.82.0 90.7%  
Inventory Days Days107 144.7%  
Debtors Days Days7115 5.9%  
Net fixed assets Rs m31,49876,920 40.9%   
Share capital Rs m393282 139.3%   
"Free" reserves Rs m43,31294,281 45.9%   
Net worth Rs m43,70594,563 46.2%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m60,637175,658 34.5%  
Interest coverage x8.13.5 231.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 126.1%   
Return on assets %6.54.1 156.3%  
Return on equity %7.84.0 196.1%  
Return on capital %9.39.2 101.2%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,846NA-   
Fx inflow Rs m26,21046,464 56.4%   
Fx outflow Rs m6,84612,712 53.9%   
Net fx Rs m19,36433,751 57.4%   
CASH FLOW
From Operations Rs m7,2406,254 115.8%  
From Investments Rs m-4,476-5,285 84.7%  
From Financial Activity Rs m-2,620-775 338.2%  
Net Cashflow Rs m144325 44.3%  

Share Holding

Indian Promoters % 69.1 46.7 148.1%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 34.7 54.9%  
FIIs % 4.5 23.7 19.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 53.4 57.0%  
Shareholders   85,212 209,931 40.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Glenmark Pharma Share Price Performance

Period ALEMBIC PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.15% -0.57% 1.18%
1-Month -4.30% 5.16% -0.75%
1-Year 105.43% 112.94% 61.82%
3-Year CAGR 0.89% 27.51% 18.16%
5-Year CAGR 13.56% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.